Abbott to sell its eye care business to J&J for about $4.33 billion
(Reuters) – Abbott Laboratories said it would sell its eye care business to Johnson & Johnson for about $4.33 billion in cash to focus on cardiovascular devices and diagnostics business. The company expanded its medical device and diagnostics businesses this year with a $25 billion deal for St. Jude Medical Inc and a $5.8 billion deal for Alere Inc . Abbott Medical Optics, which the company acquired for nearly $1.4 billion in 2009, reported sales of $1.1 billion for 2015, J&J said on Friday.
